Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients

NCT06477939 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

554

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Administration of L-TC
OTHER: Radiotherapy plus Temozolomide

Sponsor

Institut de cancérologie Strasbourg Europe

Collaborators

[object Object]